COMP <GO>
RMTI vs JNJ // GROSS PROFIT MARGIN
Rockwell Medical Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: RMTI 0
— JNJ 8
▲ GROSS PROFIT MARGIN LEADER: JNJ
LAST: $7.31 (0.00%) • MKT CAP: $29.5M
gross-margins
16.90%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
gross-margins
67.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RMTI VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RMTI | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 16.90% | 67.90% | -51.00 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -10.60% | 25.50% | -36.10 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.24% | 2.97% | -5.21 | JNJ | /fcf-yield <GO> |
| Operating Margin | -6.80% | 34.70% | -41.50 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -7.70% | 28.50% | -36.20 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | — | 6.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 8/9 | -5.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.0 | 62.1 | -21.11 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $29.5M | $662.49B | -$662.46B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RMTI REV | JNJ REV | RMTI GROSS % | JNJ GROSS % | RMTI FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $69.3M | $94.19B | 16.9% | 67.9% | -$659.0K | $19.70B |
| FY 2024 | $101.5M | $88.82B | 17.2% | 69.1% | $4.2M | $19.84B |
| FY 2023 | $0 | $85.16B | — | — | -$9.4M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RMTI // BETA —
JNJ // BETA 1.08